Revenue Breakdown
Composition ()
No data
Revenue Streams
Solventum Corp (SOLV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is MedSurg, accounting for 56.4% of total sales, equivalent to $1.22B. Other significant revenue streams include Health Information Systems and Dental Solutions. Understanding this composition is critical for investors evaluating how SOLV navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Solventum Corp maintains a gross margin of 51.40%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 7.21%, while the net margin is 3.15%. These profitability ratios, combined with a Return on Equity (ROE) of 38.86%, provide a clear picture of how effectively SOLV converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, SOLV competes directly with industry leaders such as ENSG and GH. With a market capitalization of $12.66B, it holds a leading position in the sector. When comparing efficiency, SOLV's gross margin of 51.40% stands against ENSG's 14.30% and GH's 64.63%. Such benchmarking helps identify whether Solventum Corp is trading at a premium or discount relative to its financial performance.
